STRONGBRIDGE BIOPHARMA PLC
Profile
Company Names
STRONGBRIDGE BIOPHARMA PLC
CORTENDO AB
Addresses
900 NORTHBROOK DRIVE, SUITE 200, TREVOSE, PA 19053
900 NORTHBROOK DRIVE, SUITE 200, TREVOSE, PA 19053
555 E. LANCASTER AVE., SUITE 510, RADNOR, PA 19087
Phone Numbers
(610) 254-9200
Entity Type:
OTHER
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
SWEDEN
Total Amount Raised:
$220,622,657.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-12-22
$35,000,000.00
$35,000,000.00
$0.00
Equity
3
2015-08-28
$126,000,000.00
$126,000,000.00
$0.00
Equity
2
2015-06-29
$33,224,981.00
$33,224,981.00
$0.00
Equity
1
2015-02-10
$26,397,676.00
$26,397,676.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
A. BRIAN
DAVIS
EXECUTIVE OFFICER
BRIAN
DAVIS
EXECUTIVE OFFICER
CORTENDO AB
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS II-A L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS II-B L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS II-C L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS II-A(ER) L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS II-C(ER) L.P.
| PROTECT PLUS AIR HOLDINGS, LLC
| PPA HOLDINGS, INC.
| CREDOVA HOLDINGS, INC.
| FLAMINGO ELECTRIC LLC
| FLAMINGO ELECTRIC INC.
| ORB AEROSPACE, INC.
| SUNGAS RENEWABLES INC.
| FLAMINGO MARINE INC.
JOHN
JOHNSON
DIRECTOR
ALIGN FINANCIAL GROUP, INC.
| CEMPRA HOLDINGS, LLC
| NATIONAL PLANNING CORP/CA
| CEMPRA, INC.
| GLUE NETWORKS, INC.
| NATIONAL MOLDING LLC
| CATALYTIC HOLDINGS, LLC
| HISTOGENICS CORP
| HIGHLAND COPPER CO INC.
| SNAP INFUSION LLC
| CORTENDO AB
| MERCER SONOCO INVESTMENT FUND, A SERIES OF MERCER GROUP TRUST
| MERCER ACTIVE LONG CORPORATE INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER PHOENIX INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER BUYOUT-READY FUND, A SERIES OF MERCER GROUP TRUST
| MERCER OFFICEMAX CONSOLIDATED INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER OFFICEMAX SALARIED INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MELINTA THERAPEUTICS, INC. /NEW/
| ROUNDPOINT MORTGAGE SERVICING CORP
| OPERATEMYBUILDING, INC.
| MIRATA PHARMACEUTICALS, LLC
| EVOLENT HEALTH, INC.
| HOSPITAL INNOVATIONS, LLC
| ENJOY EVERY SANDWICH LTD LIABILITY CO
| THEATRE OF THE UNIMPRESSED LTD LIABILITY CO
| ENJOY EVERY SARNIE LTD LIABILITY CO
| SECOND AVENUE JAMBOREE LTD LIABILITY CO
| STEREOPHONIC UK LTD LIABILITY CO
| SEVEN ROADS TOUR LTD LIABILITY CO
| FACE SPLIT OPEN LTD LIABILITY CO
| SHOW BIZ, ITS JUST SHOW BIZ LTD LIABILITY CO
| INTER ALIA BROADWAY LTD LIABILITY CO
JOHN
H.
JOHNSON
DIRECTOR
RICHARD
KOLLENDER
DIRECTOR
GARHENG
KONG
DIRECTOR
CEMPRA HOLDINGS, LLC
| APPLIED GENETIC TECHNOLOGIES CORP
| VIAMET PHARMACEUTICALS INC
| ALDAGEN INC
| TRANSENTERIX INC
| CANCERGUIDE DIAGNOSTICS, INC.
| SARCODE BIOSCIENCE INC.
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| HISTOGENICS CORP
| CEMPRA, INC.
| ALIMERA SCIENCES INC
| FIRST AID BEVERAGES, INC.
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| TRICE MEDICAL, INC.
| LONGWOOD OPPORTUNITY OFFSHORE FUND, LTD
| LONGWOOD OFFSHORE, LTD.
| CASTLE BIOSCIENCES INC
| STRONGBRIDGE BIOPHARMA PLC
| ACUTA OPPORTUNITY OFFSHORE FUND, LTD.
| ACUTA CAPITAL OFFSHORE FUND, LTD.
| HEALTHQUEST PARTNERS II, L.P.
| MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| VENUS CONCEPT LTD.
| ALCRESTA THERAPEUTICS, INC.
| MELINTA THERAPEUTICS, INC. /NEW/
| AVEDRO INC
| CLEANSLATE CENTERS, INC.
| BARDY DIAGNOSTICS, INC.
| HEALTHQUEST PARTNERS III, L.P.
| HEALTHQUEST AJAX II SPV, L.P.
| AJAX HEALTH II LLC
| VENUS CONCEPT INC.
| HEALTHQUEST AJAX III SPV, L.P.
| AJAX HEALTH III LLC
| HEALTHQUEST AJAX III-A SPV, L.P.
| HEALTHQUEST MADISON SPV, L.P.
| HEALTHQUEST PARTNERS IV, L.P.
| HEALTHQUEST TACTICAL OPPORTUNITIES FUND, L.P.
| HOME HOSPITAL NEWCO, INC.
| HQTOF ENDEAVOR SPV, L.P.
| HQTOF ENDEAVOR SPV-B, L.P.
| NOMAD HEALTH, INC.
STEPHEN
LONG
EXECUTIVE OFFICER
ROBERT
LUTZ
EXECUTIVE OFFICER
JOSEPH
M.
MAHADY
DIRECTOR
MATTHEW
PAULS
EXECUTIVE OFFICER, DIRECTOR
MARTEN
STEEN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
NOT APPLICABLE
Equity
2016-12-22
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-06-29

